Loading...

Patrick O'Leary, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Medicine
DepartmentHDF Comprehensive Cancer Ctr
Address1450 Third St
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. van den Hurk K, Balint B, Toomey S, O'Leary P, Unwin L, Sheahan K, McDermott EW, Murphy I, van den Oord JJ, Rafferty M, FitzGerald DM, Moran J, Cummins R, MacEneaney O, Kay EW, O'Brien CP, Finn SP, Heffron CC, Murphy M, Yela R, Power DG, Regan PJ, McDermott CM, O'Keeffe A, Orosz Z, Donnellan PP, Crown JP, Hennessy BT, Gallagher WM. High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients. Melanoma Res. 2015 Jun; 25(3):189-99. PMID: 25746038.
      View in: PubMed
    2. O'Leary P, Terrile M, Bajor M, Gaj P, Hennessy BT, Mills GB, Zagozdzon A, O'Connor DP, Brennan DJ, Connor K, Li J, Gonzalez-Angulo AM, Sun HD, Pu JX, Pontén F, Uhlén M, Jirström K, Nowis DA, Crown JP, Zagozdzon R, Gallagher WM. Peroxiredoxin-1 protects estrogen receptor a from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer. Breast Cancer Res. 2014; 16(4):R79. PMID: 25011585; PMCID: PMC4226972.
    Patrick's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP